Similar evidence also indicated that PPAR-γ is up-regulated in the liver of obese patients with NAFLD, and recently, the expression of PPAR-γ is considered as an additional reinforcing lipogenic signal, assisting SREBP-1c to trigger the development of hepatic steatosis [43]. The gene discussed is PPARG; the disease is metabolic dysfunction-associated steatotic liver disease.